Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers said.

Demand for weight loss drugs targeting GLP-1 has exploded in recent years, leading to disruptions in supply chains. Here are ...

All are welcome to join the Options Medical Weight Loss team and the Cary Chamber of Commerce for grand re-opening festivities, October 23 ST. PETERSBURG, Fla., Oct. 21, 2024 /PRNewswire ...

All are welcome to join the Options Medical Weight Loss team and the Cary Chamber of ... we're proud that within six months, the average patient loses 30 pounds of fat, including 21 percent ...

All patients were non-diabetic but obese. They tracked trends in prescriptions for GLP-1 meds used for weight loss during the last six months of 2022 and the last six months of 2023. They also ...

and after taking the popular weight loss medications. The survey of 1,000 participants between the ages of 21-75, found that more than three-quarters (78%) of consumers discussed lifestyle changes ...

All patients were non-diabetic but obese. They tracked trends in prescriptions for GLP-1 meds used for weight loss during the last six months of 2022 and the last six months of 2023. They also ...